Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04246047 |
| Title | Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 7) |
| Acronym | DREAMM 7 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | POL | NLD | ITA | ISR | GRC | ESP | BEL | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Yuma | Arizona | 85364 | United States | Details | |
| GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
| GSK Investigational Site | Kansas City | Kansas | 66205 | United States | Details | |
| GSK Investigational Site | Fairfield | Ohio | 45242 | United States | Details | |
| GSK Investigational Site | Tyler | Texas | 75702 | United States | Details | |
| GSK Investigational Site | Liverpool | New South Wales | 2170 | Australia | Details | |
| GSK Investigational Site | Wollongong | New South Wales | 2500 | Australia | Details | |
| GSK Investigational Site | Benowa | Queensland | 4217 | Australia | Details | |
| GSK Investigational Site | Brussels | 1090 | Belgium | Details | ||
| GSK Investigational Site | Brussels | 1200 | Belgium | Details | ||
| GSK Investigational Site | Ghent | 9000 | Belgium | Details | ||
| GSK Investigational Site | Roeselare | 8800 | Belgium | Details | ||
| GSK Investigational Site | Beijing | 100191 | China | Details | ||
| GSK Investigational Site | Jinan | 250012 | China | Details | ||
| GSK Investigational Site | Shenyang | 110001 | China | Details | ||
| GSK Investigational Site | Alexandroupoli | 68 100 | Greece | Details | ||
| GSK Investigational Site | Athens | 11528 | Greece | Details | ||
| GSK Investigational Site | Thessaloniki | 54007 | Greece | Details | ||
| GSK Investigational Site | Tel Aviv | 64239 | Israel | Details | ||
| GSK Investigational Site | Bergamo | 24127 | Italy | Details | ||
| GSK Investigational Site | Meldola FC | 47014 | Italy | Details | ||
| GSK Investigational Site | Milan | 20133 | Italy | Details | ||
| GSK Investigational Site | Siena | 53100 | Italy | Details | ||
| GSK Investigational Site | Aichi | 441-8570 | Japan | Details | ||
| GSK Investigational Site | Aichi | 467-8602 | Japan | Details | ||
| GSK Investigational Site | Aomori | 030-8553 | Japan | Details | ||
| GSK Investigational Site | Ehime | 790-8524 | Japan | Details | ||
| GSK Investigational Site | Fukuoka | 806-8501 | Japan | Details | ||
| GSK Investigational Site | Fukuoka | 807-8555 | Japan | Details | ||
| GSK Investigational Site | Fukuoka | 810-8563 | Japan | Details | ||
| GSK Investigational Site | Fukuoka | 815-8555 | Japan | Details | ||
| GSK Investigational Site | Gifu | 503-8502 | Japan | Details | ||
| GSK Investigational Site | Gunma | 377-0280 | Japan | Details | ||
| GSK Investigational Site | Hyōgo | 670-8540 | Japan | Details | ||
| GSK Investigational Site | Kanagawa | 221-0855 | Japan | Details | ||
| GSK Investigational Site | Kanagawa | 247-8533 | Japan | Details | ||
| GSK Investigational Site | Kochi | 781-8555 | Japan | Details | ||
| GSK Investigational Site | Nagano | 392-8510 | Japan | Details | ||
| GSK Investigational Site | Okayama | 701-1192 | Japan | Details | ||
| GSK Investigational Site | Osaka | 530-0012 | Japan | Details | ||
| GSK Investigational Site | Osaka | 545-8586 | Japan | Details | ||
| GSK Investigational Site | Shizuoka | 411-8777 | Japan | Details | ||
| GSK Investigational Site | Dordrecht | 3318 AT | Netherlands | Details | ||
| GSK Investigational Site | Groningen | 9713 GZ | Netherlands | Details | ||
| GSK Investigational Site | Chorzów | 41-500 | Poland | Details | ||
| GSK Investigational Site | Krakow | 30510 | Poland | Details | ||
| GSK Investigational Site | Lodz | 93-513 | Poland | Details | ||
| GSK Investigational Site | Lublin | 20-081 | Poland | Details | ||
| GSK Investigational Site | Lublin | 20-090 | Poland | Details | ||
| GSK Investigational Site | Nowy Sącz | 33-300 | Poland | Details | ||
| GSK Investigational Site | Poznan | 60-569 | Poland | Details | ||
| GSK Investigational Site | Warsaw | 02-781 | Poland | Details | ||
| GSK Investigational Site | Moscow | 125284 | Russia | Details | ||
| GSK Investigational Site | Nizhny Novgorod | 603126 | Russia | Details | ||
| GSK Investigational Site | Novosibirsk | 630087 | Russia | Details | ||
| GSK Investigational Site | Saint Petersburg | 191024 | Russia | Details | ||
| GSK Investigational Site | Saint Petersburg | 197 089 | Russia | Details | ||
| GSK Investigational Site | Saratov | 410028 | Russia | Details | ||
| GSK Investigational Site | Ufa | 450083 | Russia | Details | ||
| GSK Investigational Site | Pusan | 49241 | South Korea | Details | ||
| GSK Investigational Site | Ulsan | 44033 | South Korea | Details | ||
| GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
| GSK Investigational Site | Barcelona | 08916 | Spain | Details | ||
| GSK Investigational Site | Cáceres | 10003 | Spain | Details | ||
| GSK Investigational Site | Gijón | 33394 | Spain | Details | ||
| GSK Investigational Site | L'Hospitalet de Llobrega | 08908 | Spain | Details | ||
| GSK Investigational Site | Murcia | 30008 | Spain | Details | ||
| GSK Investigational Site | PamplonaNavarra | 31008 | Spain | Details | ||
| GSK Investigational Site | Salamanca | 37007 | Spain | Details |